» Articles » PMID: 7568911

Molecular Aspects of Tetanus and Botulinum Neurotoxin Poisoning

Overview
Journal Prog Neurobiol
Specialty Neurology
Date 1995 May 1
PMID 7568911
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridial neurotoxins, tetanus and the botulinum toxins A-G, are high molecular weight proteins consisting of a heavy chain which is responsible for the internalisation and a light chain possessing a zinc-dependent proteolytic activity. They exclusively proteolyse either the vesicle membrane protein, synaptobrevin or two integral plasma membrane proteins, SNAP 25 and syntaxin. Together with cytosolic proteins these proteins form the SNARE complex involved in vesicle exocytosis, and their cleavage blocks the latter process. Clostridial neurotoxins have now become powerful tools to investigate the final events occurring during secretion in neuronal, endocrine, and non-neuronal cells. They are applied to dissect the specific interactions of the SNARE protein complex with cytosolic fusogens and other modulators of exocytosis. Whereas exocytosis is not essential for the survival of cells, the organism as a whole will fall victim to a few nanograms since interneuronal and neuromuscular transmission is vital to muscular control, especially in respiration. Although all clostridial neurotoxins by their light chains attack proteins of the SNARE complex, tetanus toxin and the various botulinum toxins differ dramatically in their clinical symptoms. The biological information for this difference resides on the respective heavy chains which select different transport routes carrying the light chain from the place of entrance to the final compartment of action. So far the different transport vesicles used either by the various botulinum neurotoxins or by tetanus toxin are not yet defined. Nevertheless at least one of the botulinum toxins serves as a beneficial drug in the treatment of severe neuromuscular spasms.

Citing Articles

The threat of a new tetanus outbreak due to urban flooding disaster requires vigilance: a narrative review.

Yamaguchi J, Kinoshita K Acute Med Surg. 2023; 10(1):e839.

PMID: 37077453 PMC: 10106935. DOI: 10.1002/ams2.839.


Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles.

Keles C, Ates F Toxins (Basel). 2022; 14(11).

PMID: 36356022 PMC: 9692445. DOI: 10.3390/toxins14110772.


Annexin A2 Egress during Calcium-Regulated Exocytosis in Neuroendocrine Cells.

Gabel M, Royer C, Thahouly T, Calco V, Gasman S, Bader M Cells. 2020; 9(9).

PMID: 32917016 PMC: 7564067. DOI: 10.3390/cells9092059.


Comprehensive evaluation of gait, spasticity, and muscle morphology: A case report of a child with spastic paresis treated with Botulinum NeuroToxin-A, serial casting, and physiotherapy.

Weide G, Sloot L, Oudenhoven L, Jaspers R, Harlaar J, Buizer A Clin Case Rep. 2019; 7(9):1637-1646.

PMID: 31534717 PMC: 6745351. DOI: 10.1002/ccr3.2227.


Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats.

Kim H, Lee G, Kim M, Yang K, Kim S, Bae Y Korean J Physiol Pharmacol. 2015; 19(4):349-55.

PMID: 26170739 PMC: 4499647. DOI: 10.4196/kjpp.2015.19.4.349.